pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,782 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT05651880: Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

    Sponsor: University Hospital, Rouen. Phase: PHASE3. Conditions: Active Non-anterior Non-infectious Uveitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07431879: Acute Muscle Damage After Eccentric Quasi-Isometric Exercise of the Elbow Flexors

    Sponsor: Chinese Culture University. Phase: NA. Conditions: Acute Muscle Damage Following Resistance Exercise

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06519162: Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

    Sponsor: Chungnam National University Hospital. Phase: . Conditions: Autoimmune Hepatitis, Primary Sclerosing Cholangitis, Non-Alcoholic Fatty Liver Disease, Liver Abscess, Primary Biliary Cirrhosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04810546: Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

    Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Iron-deficiency, Pregnancy Anemia, Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07062588: Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

    Sponsor: Angitia Incorporated Limited. Phase: PHASE2. Conditions: Osteogenesis Imperfecta (OI)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07503288: Genotype and Subtype Mapping of the Hepatitis C Virus

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Hepatitis C Virus, Mutation Abnormality, RNA Positive, Unusual Subtype, Resistance

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07427888: Treatment of Cancer Pain Using an Implantable Intrathecal Pump

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Cancer Pain, Neoplasm-Related Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07069127: Hydroxyapatite-Based Home Treatment for Dentin Sensitivity in Celiac Patients

    Sponsor: University of Pavia. Phase: NA. Conditions: Celiac Disease, Dentin Hypersensitivity, Tooth Demineralization

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT04977427: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

    Sponsor: Baylor Research Institute. Phase: PHASE4. Conditions: Cataract Diabetic, Macula Edema

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07548970: Identification and Characterization of At-risk MASLD in Turkish Adults

    Sponsor: Maastricht University Medical Center. Phase: . Conditions: MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Mediterranean Diet, Lifestyle (Sedentary Behavior and Physical Activity), Vitamin D Deficiency, Hyperuricemia and MAFLD, Ferritin

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03621670: Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

    Sponsor: GlaxoSmithKline. Phase: PHASE3. Conditions: Infections, Meningococcal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06653673: The Effect of a ChatGPT-Supported Online Group-Guided Self-Help Program on Uncontrolled and Emotional Eating Behaviors and Body Image in Overweight and Obese Woman Nurses

    Sponsor: Dokuz Eylul University. Phase: NA. Conditions: Overweight (BMI > 25), Obesity and Overweight, Emotional Eating, Binge Eating

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07507669: Impact of MetaCalm on Stress of Healthy People With Acute Stress

    Sponsor: Metagenics, Inc.. Phase: NA. Conditions: Adults, Acute Stress Reaction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06497569: Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: NA. Conditions: GastroEsophageal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06801483: Ankle Strengthening in Athletes With Chronic Ankle Instability

    Sponsor: China Medical University Hospital. Phase: NA. Conditions: Chronic Ankle Instability, CAI, Athletes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05465941: PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

    Sponsor: Mayo Clinic. Phase: PHASE2. Conditions: Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, Stage IV Fallopian Tube Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Primary Peritoneal Cancer AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06799741: A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

    Sponsor: AbViro LLC. Phase: PHASE2. Conditions: DENV-3 Controlled Human Infection Model

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06638541: Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions

    Sponsor: Royal Marsden NHS Foundation Trust. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07388641: Improving Productive Community Integration in Homeless-experienced Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Homeless Persons

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07506941: Study of Functional Decline and Care Pathways in Neurosurgical Patients Over 65 Years of Age

    Sponsor: University Hospital, Toulouse. Phase: . Conditions: Ageing and Geriatric Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06238141: Expressive Writing on Stress-Related and Work-Related Outcomes Among Chinese Nursing Interns

    Sponsor: Changzhi Medical College. Phase: NA. Conditions: Stress, Psychological

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05148325: Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

    Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Advanced Solid Tumor, Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06423625: Hemorrhagic MI Prediction Score Model

    Sponsor: Rohan Dharmakumar. Phase: . Conditions: Acute Myocardial Infarction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05171725: Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

    Sponsor: Neurological Institute of Athens. Phase: . Conditions: Dementia, Alzheimer Disease, Epilepsy, Sleep Disorder, Circadian Rhythm Disorders, Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06985108: Comparison of Nasal Endotracheal Tube and Spiral Tube for Nasotracheal Intubation in Pediatric Patients

    Sponsor: Dicle University. Phase: NA. Conditions: Epistaxis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05272176: Veterans Coordinated Community Care (3C) Study

    Sponsor: Brown University. Phase: NA. Conditions: Suicide

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06437574: Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

    Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07142590: Determination of Iron Absorption and Losses in People Living at High Altitude to Investigate the Requirements in This Population Group Using a Newly Developed Technique

    Sponsor: Diego Moretti. Phase: NA. Conditions: Iron Absorption, Iron Requirements, Altitude

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07244510: Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa

    Sponsor: Sinocelltech Ltd.. Phase: PHASE2. Conditions: Hidradenitis Suppurativa (HS)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04317820: Deep Brain Reorienting in Post-traumatic Stress Disorder

    Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Phase: NA. Conditions: PTSD, Post-traumatic Stress Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06778382: Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.

    Sponsor: Shandong Cancer Hospital and Institute. Phase: PHASE2. Conditions: Colorectal Neoplasms Malignant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05571059: Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

    Sponsor: Cumberland Pharmaceuticals. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06443359: Hypofractionated Regional Nodal Irradiation in Breast Cancer

    Sponsor: Corewell Health East. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05081180: Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

    Sponsor: EMD Serono Research & Development Institute, Inc.. Phase: PHASE1. Conditions: Central Nervous System Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06685146: The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects

    Sponsor: Nicolai Jacob Wewer Albrechtsen. Phase: NA. Conditions: Glucose Metabolism, Insulin Secretion

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07533227: Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia

    Sponsor: Hua Jiang. Phase: PHASE2. Conditions: Cachexia; Cancer, Fecal Microbiota Transplantation (FMT)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06714461: A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

    Sponsor: Sanofi. Phase: . Conditions: Rheumatoid Arthritis, Psoriatic Arthritis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06415461: A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)

    Sponsor: University of Florida. Phase: PHASE1. Conditions: Sacroiliac; Backache, Pain, Back

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07021742: BioHealx® Anal Fistula Device Post Market Surveillance Study

    Sponsor: Signum Surgical USA Inc.. Phase: . Conditions: Fistula-in-ano

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05045742: Prediction of Patient Deterioration Using Machine Learning

    Sponsor: Brigham and Women's Hospital. Phase: . Conditions: Infection, Heart Failure, Chronic Obstructive Pulmonary Disease, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07480642: Caregiver Burden and Psychological Outcomes in Caregivers of Stroke Patients With Lower Urinary Tract Symptoms

    Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital. Phase: . Conditions: Stroke, Fatigue Syndrome, Chronic, Caregiver

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07343973: Post-Market Study on the Safety and Effectiveness of the OpHLINE OVD in Cataract Surgery

    Sponsor: i+Med S.Coop.. Phase: NA. Conditions: Cataract Surgery

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07551973: The Effect of an ARCS Model-Based Escape Room Simulation on Nursing Students' Knowledge, Motivation, and Self-Efficacy Regarding Surgical Site Infections

    Sponsor: Ankara Yildirim Beyazıt University. Phase: NA. Conditions: Surgical Site Infections, ARSC Motivation Model, Escape Room Simulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06983041: Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

    Sponsor: Coologics, Inc. Phase: NA. Conditions: Vulvovaginal Candidiasis (VVC), Yeast Vaginitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07280741: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators

    Sponsor: University of Sao Paulo General Hospital. Phase: PHASE4. Conditions: Autoimmune Rheumatic Diseases

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00144794: Mucopolysaccharidosis I (MPS I) Registry

    Sponsor: Genzyme, a Sanofi Company. Phase: . Conditions: Mucopolysaccharidosis I (MPS I)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07538817: ORI MONITORING IN LOW AND NORMAL FLOW ANESTHESIA APPLICATIONS

    Sponsor: Başakşehir Çam & Sakura City Hospital. Phase: . Conditions: HYPEROXY, OXYGEN RESERVE INDEX

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04301089: Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Anxiety

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07480889: Effect of Adding a Low-Dose Epinephrine Bolus Prior to Infusion on Maternal Hemodynamic Stability During Cesarean Section

    Sponsor: Cairo University. Phase: PHASE3. Conditions: Hemodynamic (MAP) Stability

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05858489: Concordance Between Mini-Mental Stats Examination (MMSE) and an Adapted Version of the MMSE in Reunion Island Population (MMS-Run)

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: . Conditions: Neurocognitive Deficit

    full page →ctgov ↗
    ← prev
    page 8 of 96
    next →